We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Search
Filters
9069 Results

Congress Abstract

BioXmark liquid fiducials to enable radiotherapy tumor boosting in rectal cancer feasibility trial
Authors: Berbée|, Maaike(1)*[maaike.berbee@maastro.nl];Opbroek|, Thirza(2);Paulissen|, John(2);Houben|, Ruud(2);Van Limbergen|, Evert(2);Ta|, Bastiaan(2);Steenbakkers|, Inge(2);Verhaegen|, Frank(2);de Ridder|, Rogier(3);Jansen|, Rob(4);Melenhorst|, Jarno(5);Bakers|, Frans(6);Grabsch|, Heike(7);Buijsen|, Jeroen(2);Canters|, Richard(2);
(1)MAASTRO Clinic, Radiation Oncology, Maastricht, The Netherlands;(2)Maastro, Radiation Oncology, Maastricht, The Netherlands;(3)Maastricht University Medical Center, Gastroenterology, Maastricht, The Netherlands;(4)Maastricht University Medical Center, Medical Oncology, Maastricht, The Netherlands;(5)Maastricht University Medical Center, Surgery, Maastricht, The Netherlands;(6)Maastricht University Medical Center, Radiology, Maastricht, The Netherlands;(7)Maastricht University Medical Center, Pathology, Maastricht, The Netherlands;
Show Affiliations
2020
Poster
ESTRO 2020

Journal Article

Influence of inhomogeneous radiosensitivity distributions and intrafractional organ movement on the tumour control probability of focused IMRT in prostate cancer
Authors: Benedikt Thomann, Ilias Sachpazidis, Khodor Koubar, Constantinos Zamboglou, Panayiotis Mavroidis, Rolf Wiehle, Anca-Ligia Grosu, Dimos Baltas
2018
Radiotherapy and Oncology

Journal Article

Reirradiation of locally recurrent rectal cancer: A systematic review
Authors: Marianne Grønlie Guren, Christine Undseth, Bernt Louni Rekstad, Morten Brændengen, Svein Dueland, Karen-Lise Garm Spindler, Rob Glynne-Jones, Kjell Magne Tveit
2014
Radiotherapy and Oncology

Congress Abstract

A 24-miRNA signature predicting HPV status in head and neck cancer
Authors: Heß|, Julia(1,2,3)*[julia.hess@helmholtz-muenchen.de];Unger|, Kristian(1,2,3);Maihoefer|, Cornelius(2,3);Schüttrumpf|, Lars(2,3);Heider|, Theresa(1,3);Weber|, Peter(1,3);Marschner|, Sebastian(2,3);Baumeister|, Philipp(3,4);Walch|, Axel(5);Woischke|, Christine(6);Werner|, Martin(7,8,9);Michael|, Baumann(10,11,12);Tinhofer|, Ingeborg(13,14);Combs|, Stephanie E. (15,16,17);Debus|, Jürgen(18,19);Schäfer |, Henning(8,20);Krause|, Mechthild(10,11,21,22,23);Linge|, Annett(10,11,21,22);Rödel|, Claus(24,25);Stuschke|, Martin(26,27);Zips|, Daniel(28,29);Ganswindt|, Ute(2,3,30);Henke|, Michael(8,20);Zitzelsberger|, Horst(1,2,3);Belka|, Claus(2,3,15);
(1)Research Unit Radiation Cytogenetics, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health, Munich, Germany;(2)Department of Radiation Oncology, University Hospital- LMU Munich, Munich, Germany;(3)Clinical Cooperation Group "Personalized Radiotherapy in Head and Neck Cancer", Helmholtz Zentrum Muenchen - German Research Center for Environmental Health, Munich, Germany;(4)Department of Otorhinolaryngology- Head and Neck Surgery, University Hospital- LMU Munich, Munich, Germany;(5)Research Unit Analytical Pathology, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health, Munich, Germany;(6)Institute of Pathology, Faculty of Medicine- Ludwig-Maximilians-University of Munich, Munich, Germany;(7)Institute for Surgical Pathology, Medical Center-University of Freiburg, Freiburg, Germany;(8)German Cancer Consortium DKTK- Partner Site Freiburg, and German Cancer Research Center DKFZ, Heidelberg, Germany;(9)Faculty of Medicine, University of Freiburg, Freiburg, Germany;(10)German Cancer Consortium DKTK- Partner Site Dresden, and German Cancer Research Center DKFZ, Heidelberg, Germany;(11)OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus- Technische Universität Dresden, Dresden, Germany;(12)DKFZ, German Cancer Research Center, Heidelberg, Germany;(13)Department of Radiooncology and Radiotherapy, Charié University Hospital Berlin, Berlin, Germany;(14)German Cancer Consortium DKTK- Partner Site Berlin, and German Cancer Research Center DKFZ, Heidelberg, Germany;(15)German Cancer Consortium DKTK- Partner Site Munich, and German Cancer Research Center DKFZ, Heidelberg, Germany;(16)Institute of Radiation Medicine IRM, Helmholtz Zentrum München- German Research Center for Environmental Health GmbH, Munich, Germany;(17)Department of Radiation Oncology- Klinikum rechts der Isar, Technische Universität München, Munich, Germany;(18)Department of Radiation Oncology- Heidelberg Ion Therapy Center HIT, University of Heidelberg, Heidelberg, Germany;(19)German Cancer Consortium DKTK- Partner Site Heidelberg, and German Cancer Research Center DKFZ, Heidelberg, Germany;(20)Department of Radiation Oncology- Medical Center- Faculty of Medicine, University of Freiburg, Freiburg, Germany;(21)National Center for Tumor Diseases NCT, Partner Site Dresden, Dresden, Germany;(22)Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus- Technische Universität Dresden, Dresden, Germany;(23)Helmholtz-Zentrum Dresden – Rossendorf, Institute of Radiooncology – OncoRay Dresden, Dresden, Germany;(24)Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany;(25)German Cancer Consortium DKTK- Partner Site Frankfurt, and German Cancer Research Center DKFZ, Heidelberg, Germany;(26)Department of Radiotherapy, Medical Faculty- University of Duisburg-Essen, Essen, Germany;(27)German Cancer Consortium DKTK- Partner Site Essen, and German Cancer Research Center DKFZ, Heidelberg, Germany;(28)Department of Radiation Oncology, Faculty of Medicine and University Hospital Tübingen- Eberhard Karls University Tübingen, Tübingen, Germany;(29)German Cancer Consortium DKTK- Partner Site Tübingen, and German Cancer Research Center DKFZ, Heidelberg, Germany;(30)Department of Therapeutic Radiology and Oncology, Innsbruck Medical University, Innsbruck, Austria;
Show Affiliations
2020
Poster Dis
ESTRO 2020

Journal Article

The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing
Authors: Pierina Navarria, Federico Pessina, Ciro Franzese, Mauro Loi, Luisa Bellu, Elena Clerici, Antonio Marco Marzo, Matteo Simonelli, Elena Lorenzi, Letterio Salvatore Politi, Lorenzo Bello, Maurizio Fornari, Zefferino Rossini, Armando Santoro, Marta Scorsetti
2021
Radiotherapy and Oncology

Journal Article

Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial
Authors: Louis Bazire, Isabelle Fromantin, Alhassane Diallo, Brigitte de la Lande, Victor Pernin, Remi Dendale, Alain Fourquet, Alexia Savignoni, Youlia M. Kirova
2015
Radiotherapy and Oncology

Congress Abstract

The treatment of anal cancer
Authors: SEBAG-MONTEFIORE|, DAVID(1)*[d.sebagmontefiore@leeds.ac.uk];
(1)UNIVERSITY OF LEEDS AND LEEDS CANCER CENTRE, LEEDS CANCER CENTRE, LEEDS, UNITED KINGDOM;
Show Affiliations
2020
ESTRO 2020

Journal Article

Radiotherapy induced dermatitis is a strong predictor for late fibrosis in head and neck cancer. The development of a predictive model for late fibrosis
Authors: Daan Nevens, Fréderic Duprez, Jean Francois Daisne, Annouschka Laenen, Wilfried De Neve, Sandra Nuyts
2017
Radiotherapy and Oncology

Congress Abstract

Gastric deformation models for adaptive radiotherapy: Personalized vs Population-based strategy
Authors:

Margot Bleeker1, Maarten C.C.M Hulshof1, Arjan Bel1, Jan-Jakob Sonke2, Astrid van der Horst1

1Amsterdam UMC, University of Amsterdam, Radiation Oncology, Amsterdam, The Netherlands; 2Netherlands Cancer Institute, Radiation Oncology, Amsterdam, The Netherlands

Show Affiliations
2021
Oral
ESTRO 2021

Educational Material

Palliative care and radiotherapy- Course Book 2021
2021
*:*